CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation Sox17 Controls Emergence and Remodeling of Nestin-Expressing Coronary Vessels Coronary Atherosclerotic Precursors of Acute Coronary Syndromes Antithrombotic Management of Elderly Patients With Coronary Artery Disease Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications

Consensusolume 41, Issue 24, 21 June 2020, Pages 2313–2330

JOURNAL:Eur Heart J. Article Link

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

J Borén, MJ Chapman, RM Krauss et al. Keywords: low-density lipoprotein; ASCVD; statin; mechanisms

Full Text PDF